Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Yoghurt study aimed to curb diabetes risk, but ended early

NCT ID NCT06836752

Prevention Sponsor: Danone Global Research & Innovation Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether eating yoghurt daily for 24 weeks could improve blood sugar control in adults with prediabetes (high risk for type 2 diabetes). Only 8 people enrolled, and the study was stopped early, so no firm conclusions can be drawn. The goal was to see if a simple dietary change might help prevent diabetes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

8 people

The number who actually took part.

Started

Sep 2025

Finished

Oct 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Signed ICF 2. Male/Female 18-65 years 3. BMI 25-35 kg/m2 4. FPG 100-125 mg/dL 5. At least one relative with T2DM 6. BW maintained (\<3%) 7. Female postmenopausal or sterile or using contraceptive method 8. Ability to comply with study protocol form 9. Access to a refrigerator at home for study products storage 10. Ability to collect and store stool samples 11. Coverage by French health insurance 12. Agreement to be registered in the national database of subjects participating in clinical research 13. Ability to complete ePRO 14. FPG 100-125 mg/dL at randomisation visit Exclusion Criteria: 1. Diagnosis of T2DM, T1DM, or on antidiabetic medications 2. Medications or supplements affecting gut microbiota or causing hyperglycemia 3. Systemic antibiotic treatment 4. Treatment interfering with BW and bariatric surgery 5. Liver, renal, cardiovascular, respiratory, endocrine, metabolic disorders, or iatrogenic immunodeficiency 6. Chronic gastro-intestinal disorders or recent use of laxatives 7. Recent surgery or general anesthesia 8. Donation/Loss of blood 9. Inability to comply with dietary restriction 10. Allergy or intolerance to study product ingredients 11. Excessive consumption of alcohol 12. Smoker 13. Pregnancy, breast-feeding or change in contraceptive methods 14. Situation interfering with optimal participation 15. Participation in other clinical study 16. Living in the same home as another participant 17. Employees, family members of Danone

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Prediabetes are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

prediabetes syndrome type 2 diabetes mellitus prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Prediabetes

Contacts and locations

Locations

  • Assistance Publique - Hôpitaux de Paris

    Paris, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.